<DOC>
	<DOCNO>NCT00618332</DOCNO>
	<brief_summary>We hypothesize patient purely seasonal allergic rhinitis decongest well subject another cause contribute symptom . These latter patient improve well intranasal steroid decongest well , potentially explain 60 % response rate prior study .</brief_summary>
	<brief_title>Can Nasal Decongestant Test Predict Treatment Outcomes Seasonal Allergic Rhinitis ?</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Nasal Decongestants</mesh_term>
	<mesh_term>Pseudoephedrine</mesh_term>
	<mesh_term>Ephedrine</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>Inclusion Criteria 1 . Males females 18 60 year age . 2 . History grass and/or ragweed allergic rhinitis . 3 . Positive skin RAST test grass , tree and/or ragweed antigen . 4 . Symptomatic time entry study . Exclusion Criteria 1 . Women childbearing potential use contraception method ( ) ( Birth control pill , depo Provera , double barrier ) well woman pregnant breastfeeding . 2 . Patients severe medical condition ( ) view investigator prohibit participation study ( heart , lung , kidney , neurological , oncologic liver disease ) . 3 . Use investigational agent last 30 day . 4 . Absence nasal symptom . 5 . Smoking . 6 . URI time screening .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>